Skip to main content
NVDA+1.06%AAPL-0.11%GOOGL+0.86%MSFT+0.93%AMZN+0.93%TSM+2.75%SPCX+7.63%META+0.19%AVGO+2.08%TSLA+0.82%SKHY-0.06%MU+0.35%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.37%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.22%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.73%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.82%USDMXN-0.79%USDZAR-0.77%AUDCHF+0.74%USDPLN-0.71%AUDJPY+0.61%CHFSEK-0.58%USDSEK-0.57%GBPCHF+0.52%NZDMXN-0.44%EURZAR-0.42%GBPTRY+0.41%GBPJPY+0.41%NOKJPY+0.40%AUDUSD+0.40%GBPZAR-0.37%EURHKD+0.37%EURPLN-0.35%NZDCHF+0.35%USDDKK-0.34%EURAUD-0.33%CADCHF+0.33%GBPHKD+0.32%AUDCAD+0.32%EURCNH+0.31%EURCHF+0.31%AUDNZD+0.31%CHFNOK-0.30%USDNOK-0.29%GBPMXN-0.28%USDCHF+0.26%GBPUSD+0.26%SGDJPY+0.26%NZDJPY+0.25%GBPSGD+0.25%CADJPY+0.23%EURSEK-0.22%NZDSGD+0.21%EURJPY+0.20%EURSGD+0.20%EURGBP-0.20%GBPCAD+0.19%EURCZK-0.19%GBPNZD+0.18%AUDDKK-0.17%USDJPY+0.17%GBPAUD-0.17%CHFSGD-0.16%USDILS+0.16%USDSGD-0.15%AUDNOK-0.13%USDTHB+0.12%CHFJPY-0.11%USDTRY+0.11%NZDUSD+0.08%USDCAD-0.06%EURUSD+0.06%EURNOK+0.06%USDCOP-0.04%USDCNH-0.04%NZDCAD+0.02%EURNZD-0.02%AUDSGD+0.01%EURCAD-0.01%EURDKK+0.01%USDHKD+0.01%UKOIL-2.85%USOIL-2.08%COCOA-1.84%XPTUSD-1.05%GAUUSD+0.75%XAUUSD+0.75%XNGUSD+0.72%GAGUSD+0.43%XAGUSD+0.42%HG1-0.15%COTTON+0.13%COFFEE+0.10%BTCUSD+0.47%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.21%ZECUSDT+2.40%DOGEUSD-1.82%XMRUSDT-0.26%LINKUSD+3.21%XLMUSD-0.04%BCHUSDT0.00%UNIUSD-2.12%LTCUSD-4.60%SUIUSD-1.71%HBARUSDT-0.84%TONUSD+12.52%TAOUSDT-1.10%AAVEUSD+0.11%DOTUSDT-1.35%ICPUSDT-4.26%ONDOUSDT-0.44%WLDUSDT+1.18%ARBUSDT-3.57%JUPUSDT-1.29%ATOMUSDT-0.91%INJUSDT+2.10%STXUSDT-0.05%FETUSDT-2.25%SEIUSDT-0.61%PYTHUSDT+1.75%TIAUSDT-0.79%IMXUSDT-2.28%GRTUSDT-1.14%OPUSDT-3.71%IOTAUSDT+3.82%WIFUSDT0.00%AXSUSDT-1.17%POLUSDT-0.44%FARTCOINUSDT+1.72%EOSUSDT+5.17%DYDXUSDT-2.68%GALAUSDT-0.92%ORDIUSDT+2.12%RONINUSDT+2.94%NOTUSDT+1.29%NVDA+1.06%AAPL-0.11%GOOGL+0.86%MSFT+0.93%AMZN+0.93%TSM+2.75%SPCX+7.63%META+0.19%AVGO+2.08%TSLA+0.82%SKHY-0.06%MU+0.35%BRK-B+0.32%LLY+0.02%AMD-0.34%JPM0.00%WMT+0.78%ASMLa+0.37%V+2.51%XOM+0.01%JNJ-1.21%INTC-2.63%0700.HK+1.23%MA+2.23%ABBV+1.12%1398.HK+1.61%CSCO+0.55%LRCX-0.49%AP2d+1.22%AMAT+0.41%CVX-0.11%ORCL+0.18%COST+0.31%CAT+0.32%BAC+0.47%KO+1.00%DELL-1.86%PG+0.71%UNH+1.80%0005.HK+1.93%HSBA.L+0.73%3988.HK+1.69%ARM-1.49%1816.HK+0.48%GE-1.04%0857.HK+1.04%MS-0.06%0939.HK+1.47%PM+1.10%1288.HK+0.92%PLNJPY+0.82%USDMXN-0.79%USDZAR-0.77%AUDCHF+0.74%USDPLN-0.71%AUDJPY+0.61%CHFSEK-0.58%USDSEK-0.57%GBPCHF+0.52%NZDMXN-0.44%EURZAR-0.42%GBPTRY+0.41%GBPJPY+0.41%NOKJPY+0.40%AUDUSD+0.40%GBPZAR-0.37%EURHKD+0.37%EURPLN-0.35%NZDCHF+0.35%USDDKK-0.34%EURAUD-0.33%CADCHF+0.33%GBPHKD+0.32%AUDCAD+0.32%EURCNH+0.31%EURCHF+0.31%AUDNZD+0.31%CHFNOK-0.30%USDNOK-0.29%GBPMXN-0.28%USDCHF+0.26%GBPUSD+0.26%SGDJPY+0.26%NZDJPY+0.25%GBPSGD+0.25%CADJPY+0.23%EURSEK-0.22%NZDSGD+0.21%EURJPY+0.20%EURSGD+0.20%EURGBP-0.20%GBPCAD+0.19%EURCZK-0.19%GBPNZD+0.18%AUDDKK-0.17%USDJPY+0.17%GBPAUD-0.17%CHFSGD-0.16%USDILS+0.16%USDSGD-0.15%AUDNOK-0.13%USDTHB+0.12%CHFJPY-0.11%USDTRY+0.11%NZDUSD+0.08%USDCAD-0.06%EURUSD+0.06%EURNOK+0.06%USDCOP-0.04%USDCNH-0.04%NZDCAD+0.02%EURNZD-0.02%AUDSGD+0.01%EURCAD-0.01%EURDKK+0.01%USDHKD+0.01%UKOIL-2.85%USOIL-2.08%COCOA-1.84%XPTUSD-1.05%GAUUSD+0.75%XAUUSD+0.75%XNGUSD+0.72%GAGUSD+0.43%XAGUSD+0.42%HG1-0.15%COTTON+0.13%COFFEE+0.10%BTCUSD+0.47%ETHUSD+6.15%USDTUSD-0.03%XRPUSD-0.54%SOLUSD-2.00%TRXUSDT-0.21%ZECUSDT+2.40%DOGEUSD-1.82%XMRUSDT-0.26%LINKUSD+3.21%XLMUSD-0.04%BCHUSDT0.00%UNIUSD-2.12%LTCUSD-4.60%SUIUSD-1.71%HBARUSDT-0.84%TONUSD+12.52%TAOUSDT-1.10%AAVEUSD+0.11%DOTUSDT-1.35%ICPUSDT-4.26%ONDOUSDT-0.44%WLDUSDT+1.18%ARBUSDT-3.57%JUPUSDT-1.29%ATOMUSDT-0.91%INJUSDT+2.10%STXUSDT-0.05%FETUSDT-2.25%SEIUSDT-0.61%PYTHUSDT+1.75%TIAUSDT-0.79%IMXUSDT-2.28%GRTUSDT-1.14%OPUSDT-3.71%IOTAUSDT+3.82%WIFUSDT0.00%AXSUSDT-1.17%POLUSDT-0.44%FARTCOINUSDT+1.72%EOSUSDT+5.17%DYDXUSDT-2.68%GALAUSDT-0.92%ORDIUSDT+2.12%RONINUSDT+2.94%NOTUSDT+1.29%
DT

Definium Therapeutics, Inc. (DFTX)

NASDAQ • Healthcare

$36.22
-$1.17 (-3.1%)
Market closed

Last close at October 5, 2026 at 20:00 UTC

Open$37.5
Day Range$35.9 - $37.74
Avg. Volume (3M)2.4M
Market Cap$4.8B
52 Week Range
$10.46$49.7
Next EarningsIn 30 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$353.7M
EPS (TTM)
-$3.44
ROA (TTM)
-31.79%
Current Ratio
6.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-5.4%Q1 2026-$0.51
-51.1%Q2 2026-$0.71
-166.2%Q3 2026-$1.44
Next

Nov 5

in 30 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -166.2%

Definium Therapeutics’ adjusted EPS missed expectations as preliminary results for the second fiscal quarter of 2026, reported August 6, 2026, showed EPS of $-1.44 trailed the $-0.54 estimate, -166%. GAAP net loss widened to roughly $159.0 million, down -271.9% year over year from about $42.7 million, alongside operating income of about -$75.1 million as the company remained in a loss position for the quarter. On a per-share basis, EPS was down -188.0% year over year versus $-0.50 a year ago. Cash flow also reflected the loss-making profile, with negative operating cash flow of roughly $52.8 million. Consensus for the next period calls for EPS of $-0.54.

Next report — what to expect

Definium Therapeutics, Inc. (DFTX) reports next on November 5, 2026. Wall Street is looking for consensus EPS of -$0.561. Historically, results have been mixed, with the company beating EPS in 2 of 8 most recent quarters; traders will be focused on the EPS print versus that benchmark.

View full earnings history

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc. is a NASDAQ-listed Healthcare company in Biotechnology that operates as a clinical-stage biopharmaceutical firm focused on brain health and neurological disorders. The company develops drug candidates for central nervous system conditions and, in qualitative terms, fits the profile of an early-stage biotech rather than a commercialized drug maker.

Name
Definium Therapeutics, Inc.
CEO
Robert Barrow
Website
definiumtx.com
Industry
Healthcare
Employees
106

Today's Snapshot

AI-generated

DFTX closed 3.1% lower at 36.23.

Trading Volume

Above 10d avg 2.3M

2.6M

vs S&P 500 Today

Strong Underperformance

-3.79%

Updated: October 6, 2026 at 12:13 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
DFTX exhibits a bearish tilt at 36.23, with price weakness confirmed by negative CCI and momentum and a below‑average MACD. Trend strength remains limited (ADX about 12), implying the directional move lacks conviction, while the stock trades below its short- and intermediate-term averages but above the 200-day level, creating a mixed timeframe picture. On-balance volume is negative and ATR indicates elevated percentage volatility, and the pivot sits above the current price as nearby resistance. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$28.37 - $39.10
    Sell
  • RSI (14)39.64
    Neutral
  • Stochastic %K (14, 3, 3)26.11
    Neutral
  • MACD Level (12, 26)-0.99
    Neutral

Peers & Related Assets

KODKodiak Sciences Inc.
$93.81-0.7%
TNGXTango Therapeutics, Inc.
$23.08-0.7%
NRIXNurix Therapeutics, Inc.
$22.88-0.5%
URGNUroGen Pharma Ltd.
$42.78+3.3%
FTREFortrea Holdings Inc.
$21.11+5.5%
XNCRXencor, Inc.
$25.63+3.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.